Glucose intolerance during hormonal therapy for prostate cancer

Depression during hormonal treatment of prostate cancer.

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy

BACKGROUND The outcome of patients after radiotherapy (RT) for localized prostate cancer in case of prostate-specific antigen (PSA) progression during primary hormonal therapy (HT) is not well known. METHODS A group of 27 patients presenting with PSA progression during primary HT for local prostate cancer RT was identified among patients who were treated in the years 2000-2004 either using ex...

Recent advances in hormonal therapy for advanced prostate cancer.

Hormonal treatment of advanced prostate cancer should be considered for patients who have stages C and D1 disease, a high risk of recurrence after local therapy, or prostate-specific antigen-measured recurrence after local treatment. This approach is dependent on most prostate cancer cells being androgen-dependent, but androgen-independent cells may arise after several years of hormonal therapy...

Hormonal and Chemotherapeutic Systemic Therapy for Metastatic Prostate Cancer.

BACKGROUND: Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer death in men in the United States. It is estimated that over 300,000 men will have been diagnosed with prostate cancer in 1996, and more than 40,000 will have died of this disease. METHODS: The authors combined their experience with a review of the literature on management of this disease ...

Novel hormonal therapy for castration-resistant prostate cancer.

Prostate cancer is the most common cancer in European men and the second leading cause of death [1]. For patients who relapse after treatment of organ-confined disease or those who have initial metastatic disease, testosterone suppression is the mainstay of therapy. Manipulating the androgen receptor (AR) axis was the first method discovered, which could actively control prostate cancer. In fac...